Written especially for nurses caring for patients with cancer the
2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug
therapy in terms of the nursing process: nursing diagnoses
etiologies of toxicities and key points for nursing assessment
intervention and evaluation. This essential reference provides
valuable information on effective symptom management patient
education and chemotherapy administration.
DESCRIPTION
Completely revised and updated the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content attention to understanding the immune checkpoint inhibitors new information about immunotherapy new drugs and their indications and updated indications and side effects for drugs recently approved by the FDA.
Key Features
- Provides valuable information on effective symptom management patient education and chemotherapy administration.
- Completely revised and updated includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content attention to understanding the immune checkpoint inhibitors new information about immunotherapy new drugs and their indications and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™) calaspargase pegol-mknl (Asparlas™) Daunorubicin and cytarabine liposome for injection (Vyxeos®) glucarpidase (Voraxaze®) alpelisib (Piqray®) binimetinib (Mektovi®) dacomitinib (Vizimpro®) Duvelisib (Copiktra®) encorafenib (Braftovi®) erdafitinib (Balversa™) lorlatinib (Lorbrena®) anakinra (Kineret®) baricitinib (Olumiant®) sarilumab (Kevzara®) aprepitant injectable emulsion (Cinvanti®) granisetron hydrochloride extended-release injection (Sustol®) letermovir (Prevymis™) omadacycline (Nuzyra™) meropenem/vaborbactam (Vabomere™) Plazomicin (Zemdri™) baloxavir marboxil (Xofluza™) imipenem/cilastatin sodium/relebactam (Recarbrio™) eravacycline (Xerava™) delafloxacin (Baxdela™)
DESCRIPTION
Completely revised and updated the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content attention to understanding the immune checkpoint inhibitors new information about immunotherapy new drugs and their indications and updated indications and side effects for drugs recently approved by the FDA.
Key Features
- Provides valuable information on effective symptom management patient education and chemotherapy administration.
- Completely revised and updated includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content attention to understanding the immune checkpoint inhibitors new information about immunotherapy new drugs and their indications and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™) calaspargase pegol-mknl (Asparlas™) Daunorubicin and cytarabine liposome for injection (Vyxeos®) glucarpidase (Voraxaze®) alpelisib (Piqray®) binimetinib (Mektovi®) dacomitinib (Vizimpro®) Duvelisib (Copiktra®) encorafenib (Braftovi®) erdafitinib (Balversa™) lorlatinib (Lorbrena®) anakinra (Kineret®) baricitinib (Olumiant®) sarilumab (Kevzara®) aprepitant injectable emulsion (Cinvanti®) granisetron hydrochloride extended-release injection (Sustol®) letermovir (Prevymis™) omadacycline (Nuzyra™) meropenem/vaborbactam (Vabomere™) Plazomicin (Zemdri™) baloxavir marboxil (Xofluza™) imipenem/cilastatin sodium/relebactam (Recarbrio™) eravacycline (Xerava™) delafloxacin (Baxdela™)
Show More >
Oncology Nursing Drug Handbook / What's New in vUnknown
- Keep your app updated to get the latest experience on your
Android phones & tablets
- We want you to get notified about exclusive offers, promotions, & discounts. This updates does this directly through in-app notifications
- We have also updated our billing system with the latest Google Billing Library to ensure smoother and more secure transactions.
- Our app is now compatible with Android 13, ensuring compatibility with the latest features and improvements offered by the Android platform
- We want you to get notified about exclusive offers, promotions, & discounts. This updates does this directly through in-app notifications
- We have also updated our billing system with the latest Google Billing Library to ensure smoother and more secure transactions.
- Our app is now compatible with Android 13, ensuring compatibility with the latest features and improvements offered by the Android platform